Cervical human papillomavirus prevalence and genotype distribution among hybrid capture 2 positive women 15 to 64 years of age in the Gurage zone, rural Ethiopia

Cross-neutralizing antibodies elicited by the Cervarix® human papillomavirus vaccine display a range of Alpha-9 inter-type specificities

(2014) Sara L. Bissett et al.   VACCINE

Neutralizing and cross-neutralizing antibody titres induced by bivalent and quadrivalent human papillomavirus vaccines in the target population of organized vaccination programmes

(2014) Luisa Barzon et al.   VACCINE

Prevalence, incidence and risk factors for anogenital warts in Sub Saharan Africa: a systematic review and meta analysis

(2013) Cecily Banura et al.   Infectious Agents and Cancer

Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer

(2012) Peng Guan et al.   INTERNATIONAL JOURNAL OF CANCER

The age-specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria: Implications for screen-and-treat strategies

(2011) Julia C. Gage et al.   INTERNATIONAL JOURNAL OF CANCER

A population-based cross-sectional study of age-specific risk factors for high risk human papillomavirus prevalence in rural Nigeria

(2011) Megan A Clarke et al.   Infectious Agents and Cancer

Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication

(2010) Ni Li et al.   INTERNATIONAL JOURNAL OF CANCER

Post-licensure monitoring of HPV vaccine in the United States

(2010) Lauri E. Markowitz et al.   VACCINE

HPV infection in Europe

(2009) Hugo De Vuyst et al.   EUROPEAN JOURNAL OF CANCER

Chimeric L1-L2 Virus-Like Particles as Potential Broad-Spectrum Human Papillomavirus Vaccines

(2009) C. Schellenbacher et al.   JOURNAL OF VIROLOGY

Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline

(2009) Mark Schiffman et al.   Infectious Agents and Cancer

Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older

(2008) Chris J.L.M. Meijer et al.   INTERNATIONAL JOURNAL OF CANCER

Human Papillomavirus Genotype Specificity of Hybrid Capture 2

(2008) P. E. Castle et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Prevalence and risk factors for carcinogenic human papillomavirus infections in rural Rakai, Uganda

(2008) M Safaeian et al.   SEXUALLY TRANSMITTED INFECTIONS